OPKO Health Cash Flow Statement
NASDAQ: OPKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OPKO Health free cash flow
In fiscal 2025, OPKO Health generated -$178.5 million of operating cash flow and spent $12.3 million on capital expenditures. That left free cash flow of -$190.8 million, a free-cash-flow margin of -31.4% of revenue. OPKO Health returned $47.0 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
OPKO Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -225.68M | -53.22M | -188.86M | -328.40M | -30.14M | 30.59M | -314.93M | -153.04M | -305.25M | -48.36M |
| Net Income growth (YoY) | — | — | — | — | -198.55% | — | — | — | — | — |
| Depreciation & Amortization | 91.63M | 98.18M | 105.30M | 108.66M | 78.72M | 85.36M | 93.81M | 97.34M | 102.09M | 96.58M |
| Stock-Based Compensation | 10.71M | 11.05M | 11.41M | 18.51M | 13.63M | 8.95M | 13.42M | 21.76M | 28.31M | 42.69M |
| Change in Working Capital | 11.90M | -16.43M | 21.02M | 43.70M | -24.30M | -114.93M | -57.25M | -60.71M | 43.84M | -36.82M |
| Operating Cash Flow | -178.54M | -183.49M | -28.20M | -95.19M | 38.34M | 39.48M | -172.52M | -109.14M | -92.08M | 32.05M |
| Capital Expenditures | -12.28M | -25.01M | -16.27M | -24.58M | -32.16M | -33.68M | -12.74M | -27.86M | -46.52M | -18.55M |
| Investing Cash Flow | 230.30M | 352.21M | -18.20M | 91.04M | 35.95M | -18.33M | -13.27M | -26.12M | -46.67M | -20.70M |
| Share Repurchases | -47.04M | -90.22M | 0 | 0 | — | — | — | — | — | — |
| Debt Issued | 0 | 250.00M | 0 | 0 | — | — | — | — | — | — |
| Debt Repaid | — | -146.29M | -3.00M | 0 | 0 | 0 | -28.80M | 0 | 0 | — |
| Financing Cash Flow | -118.06M | 184.17M | -11.30M | 22.97M | -10.35M | -35.08M | 175.25M | 140.91M | 61.04M | -35.20M |
| Net Change in Cash | -62.87M | 349.73M | -57.31M | 18.48M | 62.50M | -13.24M | -11.02M | 4.97M | -77.23M | -24.86M |
| Free Cash Flow | -190.82M | -208.50M | -44.47M | -119.77M | 6.18M | 5.79M | -185.26M | -137.00M | -138.60M | 13.50M |
This table shows 10 annual periods of OPKO Health's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OPK's reporting calendar. What is a cash flow statement?